Human Nutrition Unit, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, Reus, Spain; the Nutrition Unit, University Hospital of Sant Joan de Reus, Reus, Spain; and the Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Nutr Rev. 2019 Oct 1;77(10):691-709. doi: 10.1093/nutrit/nuz042.
Previous meta-analyses evaluating the association between nut consumption and the risk of cardiovascular disease (CVD) had substantial methodological limitations and lacked recently published large prospective studies; hence, making an updated meta-analysis highly desirable.
To update the clinical guidelines for nutrition therapy in relation to the European Association for the Study of Diabetes (EASD), a systematic review and meta-analysis of prospective studies was conducted using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to summarize the evidence of the association between total nuts, specific types of nuts, and the incidence of, and mortality from, CVD outcomes.
Relevant articles were identified by searching the PubMed and Cochrane databases.
Two independent researchers screened the articles to identify those that met the inclusion criteria.
The inverse variance method with fixed-effect or random-effects models was used to pool data across studies (expressed as risk ratio [RR] and 95% confidence interval [CI]). Heterogeneity was tested and quantified using the Cochrane Q test and I2-statistic, respectively. The GRADE system was used to assess the quality of the evidence.
Nineteen studies were included in the analyses. The results revealed an inverse association between total nut consumption (comparing highest vs lowest categories) and CVD incidence (RR, 0.85; 95%CI, 0.800.91; I2, 0%), CVD mortality (RR, 0.77; 95%CI, 0.72-0.82; I2, 3%), coronary heart disease (CHD) incidence (RR, 0.82; 95%CI, 0.69-0.96; I2, 74%), CHD mortality (RR, 0.76; 95%CI, 0.67-0.86; I2, 46%), stroke mortality (RR, 0.83; 95%CI, 0.75-0.93; I2, 0%), and atrial fibrillation (RR, 0.85; 95%CI, 0.73-0.99; I2, 0%). No association was observed with stroke incidence and heart failure. The certainty of the evidence ranged from moderate to very low.
This systematic review and meta-analysis revealed a beneficial role of nut consumption in reducing the incidence of, and mortality from, different CVD outcomes.
先前评估坚果摄入与心血管疾病 (CVD) 风险之间关联的荟萃分析存在重大方法学局限性,且缺乏最近发表的大型前瞻性研究;因此,进行更新的荟萃分析非常必要。
更新与欧洲糖尿病研究协会 (EASD) 相关的营养治疗临床指南,我们使用推荐分级的评估、制定与评价 (GRADE) 系统对前瞻性研究进行了系统评价和荟萃分析,以总结总坚果、特定类型坚果与 CVD 结局发生率和死亡率之间关联的证据。
通过检索 PubMed 和 Cochrane 数据库确定相关文章。
两名独立研究人员筛选文章以确定符合纳入标准的文章。
使用固定效应或随机效应模型的逆方差法对研究间数据进行汇总(表示为风险比 [RR] 和 95%置信区间 [CI])。使用 Cochrane Q 检验和 I2 统计量分别测试和量化异质性。使用 GRADE 系统评估证据质量。
纳入的分析共有 19 项研究。结果显示,总坚果摄入量(比较最高和最低类别)与 CVD 发生率(RR,0.85;95%CI,0.800.91;I2,0%)、CVD 死亡率(RR,0.77;95%CI,0.72-0.82;I2,3%)、冠心病 (CHD) 发生率(RR,0.82;95%CI,0.69-0.96;I2,74%)、CHD 死亡率(RR,0.76;95%CI,0.67-0.86;I2,46%)、卒中死亡率(RR,0.83;95%CI,0.75-0.93;I2,0%)和心房颤动(RR,0.85;95%CI,0.73-0.99;I2,0%)呈负相关。卒中发生率和心力衰竭与坚果摄入无关联。证据的确定性范围为中等到极低。
本系统评价和荟萃分析显示,坚果摄入可降低不同 CVD 结局的发生率和死亡率,发挥有益作用。